Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.3M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+451K
-
Total reported value, excl. options
-
$213M
-
Value change
-
+$4.53M
-
Number of buys
-
25
-
Number of sells
-
-7
-
Price
-
$10.08
Significant Holders of Artiva Biotherapeutics, Inc. - Common Stock (ARTV) as of Q4 2024
58 filings reported holding ARTV - Artiva Biotherapeutics, Inc. - Common Stock as of Q4 2024.
Artiva Biotherapeutics, Inc. - Common Stock (ARTV) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 24.3M outstanding shares and own 87.13% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.85M shares), 5AM Venture Management, LLC (2.35M shares), VR Adviser, LLC (1.61M shares), venBio Partners LLC (1.52M shares), BlackRock, Inc. (1.05M shares), Capital World Investors (915K shares), VANGUARD GROUP INC (867K shares), FRANKLIN RESOURCES INC (520K shares), GEODE CAPITAL MANAGEMENT, LLC (316K shares), and Samsara BioCapital, LLC (292K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.